Inmune Bio Stock Price History
| INMB Stock | USD 7.67 1.14 17.46% |
Below is the normalized historical share price chart for INmune Bio extending back to February 04, 2019. This chart has been adjusted for all splits and dividends and is plotted against all major global economic recessions. As of today, the current price of INmune Bio stands at 7.67, as last reported on the 22nd of January, with the highest price reaching 7.70 and the lowest price hitting 6.59 during the day.
If you're considering investing in INmune Stock, it is important to understand the factors that can impact its price. INmune Bio appears to be slightly risky, given 3 months investment horizon. INmune Bio holds Efficiency (Sharpe) Ratio of 0.14, which attests that the entity had a 0.14 % return per unit of risk over the last 3 months. By evaluating INmune Bio's technical indicators, you can evaluate if the expected return of 0.79% is justified by implied risk. Please utilize INmune Bio's Downside Deviation of 4.44, risk adjusted performance of 0.1046, and Market Risk Adjusted Performance of 2.32 to validate if our risk estimates are consistent with your expectations.
At present, INmune Bio's Common Stock is projected to increase significantly based on the last few years of reporting. The current year's Other Stockholder Equity is expected to grow to about 192.2 M, whereas Total Stockholder Equity is forecasted to decline to about 33.6 M. . At present, INmune Bio's Price Book Value Ratio is projected to increase significantly based on the last few years of reporting. The current year's Price To Book Ratio is expected to grow to 5.02, whereas Price To Sales Ratio is forecasted to decline to 1,427. INmune Stock price history is provided at the adjusted basis, taking into account all of the recent filings.
IPO Date 4th of February 2019 | 200 Day MA 7.2555 | 50 Day MA 5.2482 | Beta 1.852 |
INmune |
Sharpe Ratio = 0.1408
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | INMB | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 5.64 actual daily | 50 50% of assets are less volatile |
Expected Return
| 0.79 actual daily | 15 85% of assets have higher returns |
Risk-Adjusted Return
| 0.14 actual daily | 11 89% of assets perform better |
Based on monthly moving average INmune Bio is performing at about 11% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of INmune Bio by adding it to a well-diversified portfolio.
Price Book 3.6978 | Enterprise Value Ebitda (5.31) | Price Sales 3.4 K | Shares Float 14.3 M | Wall Street Target Price 19.8333 |
INmune Bio Stock Price History Chart
There are several ways to analyze INmune Stock price data. The simplest method is using a basic INmune candlestick price chart, which shows INmune Bio price history and the buying and selling dynamics of a specified period. Many traders also use subjective judgment to their trading calls, avoiding the need to trade based on technical analysis.
| Highest Price | January 22, 2025 | 7.67 |
| Lowest Price | December 20, 2024 | 4.4 |
INmune Bio January 22, 2025 Stock Price Synopsis
Various analyses of INmune Bio's daily price changes, such as its Balance Of Power or Price Action, are crucial when deciding whether to buy, hold, or sell INmune Stock. It can be used to describe the percentage change in the price of INmune Bio from one trading day to the next and could be a valuable metric for traders and investors to gauge the volatility and momentum of INmune Stock.| INmune Bio Price Rate Of Daily Change | 1.17 | |
| INmune Bio Accumulation Distribution | 108,111 | |
| INmune Bio Price Action Indicator | 1.09 | |
| INmune Bio Price Daily Balance Of Power | 1.03 |
INmune Bio January 22, 2025 Stock Price Analysis
INmune Stock Price History Data
The price series of INmune Bio for the period between Thu, Oct 24, 2024 and Wed, Jan 22, 2025 has a statistical range of 2.32 with a coefficient of variation of 11.73. Under current investment horizon, the daily prices are spread out with arithmetic mean of 5.33. The median price for the last 90 days is 5.18.| Open | High | Low | Close | Volume | ||
| 01/22/2025 | 6.59 | 7.70 | 6.59 | 7.67 | 749,959 | |
| 01/21/2025 | 6.52 | 6.57 | 6.16 | 6.53 | 328,779 | |
| 01/17/2025 | 6.74 | 6.80 | 6.04 | 6.45 | 379,964 | |
| 01/16/2025 | 6.52 | 6.83 | 6.11 | 6.72 | 631,474 | |
| 01/15/2025 | 6.09 | 6.39 | 5.82 | 6.28 | 405,069 | |
| 01/14/2025 | 6.67 | 6.68 | 5.86 | 5.96 | 603,555 | |
| 01/13/2025 | 5.79 | 6.84 | 5.76 | 6.54 | 1,310,910 | |
| 01/10/2025 | 5.35 | 5.67 | 5.15 | 5.49 | 283,671 | |
| 01/08/2025 | 5.66 | 5.72 | 5.22 | 5.30 | 254,216 | |
| 01/07/2025 | 5.45 | 6.15 | 5.45 | 5.57 | 489,221 | |
| 01/06/2025 | 5.38 | 5.63 | 5.36 | 5.41 | 370,435 | |
| 01/03/2025 | 5.01 | 5.42 | 5.01 | 5.30 | 408,679 | |
| 01/02/2025 | 4.73 | 5.19 | 4.73 | 4.93 | 270,838 | |
| 12/31/2024 | 4.93 | 4.96 | 4.61 | 4.67 | 213,611 | |
| 12/30/2024 | 4.58 | 4.72 | 4.46 | 4.65 | 242,309 | |
| 12/27/2024 | 4.78 | 4.87 | 4.55 | 4.65 | 258,142 | |
| 12/26/2024 | 4.51 | 4.77 | 4.45 | 4.73 | 190,130 | |
| 12/24/2024 | 4.59 | 4.61 | 4.40 | 4.49 | 96,900 | |
| 12/23/2024 | 4.38 | 4.59 | 4.38 | 4.55 | 225,281 | |
| 12/20/2024 | 4.36 | 4.60 | 4.32 | 4.40 | 402,171 | |
| 12/19/2024 | 4.68 | 4.79 | 4.36 | 4.42 | 242,846 | |
| 12/18/2024 | 4.98 | 5.08 | 4.48 | 4.57 | 273,004 | |
| 12/17/2024 | 5.08 | 5.16 | 4.85 | 4.98 | 195,231 | |
| 12/16/2024 | 4.74 | 5.10 | 4.62 | 5.08 | 165,683 | |
| 12/13/2024 | 4.84 | 4.85 | 4.62 | 4.75 | 410,724 | |
| 12/12/2024 | 5.26 | 5.27 | 4.86 | 4.87 | 169,373 | |
| 12/11/2024 | 5.53 | 5.53 | 5.20 | 5.25 | 198,746 | |
| 12/10/2024 | 5.33 | 5.68 | 5.27 | 5.44 | 253,124 | |
| 12/09/2024 | 4.93 | 5.36 | 4.93 | 5.32 | 195,215 | |
| 12/06/2024 | 4.90 | 4.96 | 4.81 | 4.90 | 128,486 | |
| 12/05/2024 | 5.02 | 5.05 | 4.74 | 4.87 | 163,916 | |
| 12/04/2024 | 5.19 | 5.21 | 4.90 | 5.05 | 283,839 | |
| 12/03/2024 | 5.42 | 5.76 | 5.14 | 5.17 | 345,651 | |
| 12/02/2024 | 5.09 | 5.41 | 5.00 | 5.40 | 200,956 | |
| 11/29/2024 | 4.92 | 5.05 | 4.86 | 5.05 | 68,255 | |
| 11/27/2024 | 4.99 | 5.13 | 4.88 | 4.89 | 172,455 | |
| 11/26/2024 | 4.80 | 4.93 | 4.68 | 4.88 | 131,959 | |
| 11/25/2024 | 4.93 | 5.10 | 4.80 | 4.80 | 178,732 | |
| 11/22/2024 | 4.76 | 4.98 | 4.70 | 4.87 | 129,887 | |
| 11/21/2024 | 4.56 | 4.86 | 4.47 | 4.76 | 186,960 | |
| 11/20/2024 | 4.70 | 4.70 | 4.45 | 4.56 | 188,610 | |
| 11/19/2024 | 4.80 | 4.82 | 4.60 | 4.71 | 223,392 | |
| 11/18/2024 | 5.00 | 5.08 | 4.81 | 4.87 | 284,378 | |
| 11/15/2024 | 5.30 | 5.34 | 4.91 | 4.96 | 388,310 | |
| 11/14/2024 | 5.67 | 5.67 | 5.42 | 5.44 | 146,047 | |
| 11/13/2024 | 5.71 | 5.97 | 5.60 | 5.72 | 181,209 | |
| 11/12/2024 | 6.04 | 6.17 | 5.65 | 5.66 | 209,837 | |
| 11/11/2024 | 6.14 | 6.26 | 6.09 | 6.13 | 122,316 | |
| 11/08/2024 | 6.20 | 6.22 | 6.09 | 6.13 | 124,764 | |
| 11/07/2024 | 6.46 | 6.50 | 6.11 | 6.22 | 154,929 | |
| 11/06/2024 | 6.39 | 6.59 | 6.24 | 6.43 | 267,849 | |
| 11/05/2024 | 6.29 | 6.35 | 6.04 | 6.19 | 132,529 | |
| 11/04/2024 | 6.04 | 6.35 | 5.96 | 6.25 | 183,260 | |
| 11/01/2024 | 5.94 | 6.37 | 5.89 | 6.04 | 225,027 | |
| 10/31/2024 | 5.91 | 5.98 | 5.67 | 5.85 | 168,943 | |
| 10/30/2024 | 6.26 | 6.46 | 5.76 | 5.95 | 311,245 | |
| 10/29/2024 | 6.25 | 6.66 | 6.15 | 6.30 | 534,015 | |
| 10/28/2024 | 5.65 | 6.53 | 5.65 | 6.17 | 622,677 | |
| 10/25/2024 | 5.30 | 5.74 | 5.21 | 5.42 | 496,066 | |
| 10/24/2024 | 5.00 | 5.35 | 4.97 | 5.22 | 310,767 | |
| 10/23/2024 | 5.08 | 5.18 | 4.89 | 5.00 | 175,186 |
About INmune Bio Stock history
INmune Bio investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for INmune is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in INmune Bio will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing INmune Bio stock prices may prove useful in developing a viable investing in INmune Bio
| Last Reported | Projected for Next Year | ||
| Common Stock Shares Outstanding | 20.7 M | 14.8 M | |
| Net Loss | -24.6 M | -23.3 M |
INmune Bio Quarterly Net Working Capital |
|
INmune Bio Stock Technical Analysis
INmune Bio technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Did you try this?
Run Portfolio Analyzer Now
Portfolio AnalyzerPortfolio analysis module that provides access to portfolio diagnostics and optimization engine |
| All Next | Launch Module |
INmune Bio Technical and Predictive Indicators
Predictive indicators are helping investors to find signals for INmune Bio's price direction in advance. Along with the technical and fundamental analysis of INmune Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of INmune to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.
| Risk Adjusted Performance | 0.1046 | |||
| Jensen Alpha | 0.5666 | |||
| Total Risk Alpha | 0.4128 | |||
| Sortino Ratio | 0.1232 | |||
| Treynor Ratio | 2.31 |
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
Complementary Tools for INmune Stock analysis
When running INmune Bio's price analysis, check to measure INmune Bio's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy INmune Bio is operating at the current time. Most of INmune Bio's value examination focuses on studying past and present price action to predict the probability of INmune Bio's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move INmune Bio's price. Additionally, you may evaluate how the addition of INmune Bio to your portfolios can decrease your overall portfolio volatility.
| My Watchlist Analysis Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like | |
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Portfolio File Import Quickly import all of your third-party portfolios from your local drive in csv format | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Portfolio Comparator Compare the composition, asset allocations and performance of any two portfolios in your account | |
| Piotroski F Score Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals |